BioCryst Pharmaceuticals
BCRX
#5073
Rank
NZ$2.76 B
Marketcap
NZ$13.14
Share price
-3.07%
Change (1 day)
0.80%
Change (1 year)

BioCryst Pharmaceuticals (BCRX) - Net assets

Net assets on the balance sheet as of September 2025 : -NZ$0.68 Billion

According to BioCryst Pharmaceuticals 's latest financial reports the company has -NZ$0.68 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

BioCryst Pharmaceuticals - Net assets on balance sheet (from 2001 to 2025)

Net assets by year

Year Net assets Change
2024-12-31$-NZ$0.85 Billion17.16%
2023-12-31$-NZ$0.73 Billion55.24%
2022-12-31$-NZ$0.47 Billion196.24%
2021-12-31$-NZ$0.16 Billion486.73%
2020-12-31$-NZ$26.7 Million-147%
2019-12-31$NZ$56.79 M-22.62%
2018-12-31$NZ$73.4 M-37.77%
2017-12-31$NZ$0.11 B5077.52%
2016-12-31$NZ$2.27 M-96.73%
2015-12-31$NZ$69.72 M-27.77%
2014-12-31$NZ$96.53 M-7145.02%
2013-12-31$-NZ$1.38 Million148.28%
2012-12-31$-NZ$0.56 Million-102.91%
2011-12-31$NZ$18.97 M-77.66%
2010-12-31$NZ$84.9 M-28.51%
2009-12-31$NZ$0.11 B48.46%
2008-12-31$NZ$80 M-5.58%
2007-12-31$NZ$84.73 M182.18%
2006-12-31$NZ$30.02 M-64.88%
2005-12-31$NZ$85.5 M107.98%
2004-12-31$NZ$41.11 M-6.06%
2003-12-31$NZ$43.76 M-42.93%
2002-12-31$NZ$76.67 M-43.96%
2001-12-31$NZ$0.13 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Repligen
RGEN
NZ$3.60 B-637.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
NZ$2.28 B-440.33%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoViricides
NNVC
NZ$13.01 M-101.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
-NZ$0.28 Billion-59.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
NZ$37.14 B-5,631.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
NZ$1.03 B-254.26%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
NZ$36.65 B-5,559.29%๐Ÿ‡ฌ๐Ÿ‡ง UK
Emergent BioSolutions
EBS
NZ$1.00 B-250.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
NZ$12.16 M-101.81%๐Ÿ‡บ๐Ÿ‡ธ USA